Oxazepam Capsule
Product Images NDC 71610-639

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Oxazepam (NDC 71610-639). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 15 mg (71610 0639 30)

Oxazepam USP 15 mg capsules in a bottle containing 30 capsules. The label includes storage instructions, manufacturer Frontida BioPharm Inc. Philadelphia, PA, and repackager Aphena Pharma Solutions - Tennessee, LLC in Cookeville, TN. The label specifies prescription use only and includes warnings about habit-forming potential.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

The Following Structural Formula For Oxazepam, Is 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2h-1,4-benzodiazepin-2-one (Oxazepam Capsules Usp 01)

Chemical structure of Oxazepam showing its molecular framework with a chlorine atom and key functional groups. The formula C15H11ClN2O2 is visible alongside the diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.